GLP1R and ischemic stroke: Additionally, OW GLP-1 RA users had a 22% lower risk of MI (HR [95% CI] 0.78 [0.67–0.92]) and a 24% lower risk of the composite of ischemic stroke or MI (HR [95% CI] 0.76 [0.68–0.86]) than did DPP-4i users.